ECCO 2017: Rising melanoma death rates could be blunted by new therapies by 2050
By 2050 the death rates from malignant melanoma will have decreased from their current levels…
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
By 2050 the death rates from malignant melanoma will have decreased from their current levels…
A new study provides some of the strongest evidence to date that microorganisms living in…
A naturally occurring hormone that plays an important role in foetal development may be the…
A large-scale, population based study led by Dr. Laurent Azoulay, Senior Investigator with the Lady…
Treating head and neck cancer patients with a twice-daily radiation therapy combined with chemotherapy could…
Once breast cancer spreads through the body, it can degrade a patient’s healthy bones, causing…
Stuart Pitson, University of South Australia It’s a sobering fact that one in two Australian…
A combination of two chemotherapy drugs – gemcitabine and capecitabine – should be the new standard of care for…
By Taylor Kubota In hopes of creating better access to medical care, Stanford researchers have…
Scientists at the Walter and Eliza Hall Institute in Melbourne have discovered the cells that…